ATE454906T1 - Feste zusammensetzung mit einem protonenpumpenhemmer - Google Patents

Feste zusammensetzung mit einem protonenpumpenhemmer

Info

Publication number
ATE454906T1
ATE454906T1 AT04749149T AT04749149T ATE454906T1 AT E454906 T1 ATE454906 T1 AT E454906T1 AT 04749149 T AT04749149 T AT 04749149T AT 04749149 T AT04749149 T AT 04749149T AT E454906 T1 ATE454906 T1 AT E454906T1
Authority
AT
Austria
Prior art keywords
proton pump
pump inhibitor
solid composition
pellets
composition containing
Prior art date
Application number
AT04749149T
Other languages
English (en)
Inventor
Eva Blychert
Marjo Janssen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE454906T1 publication Critical patent/ATE454906T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04749149T 2003-07-11 2004-07-08 Feste zusammensetzung mit einem protonenpumpenhemmer ATE454906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48679503P 2003-07-11 2003-07-11
PCT/SE2004/001113 WO2005004921A1 (en) 2003-07-11 2004-07-08 Solid composition comprising a proton pump inhibitor

Publications (1)

Publication Number Publication Date
ATE454906T1 true ATE454906T1 (de) 2010-01-15

Family

ID=34062141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04749149T ATE454906T1 (de) 2003-07-11 2004-07-08 Feste zusammensetzung mit einem protonenpumpenhemmer

Country Status (7)

Country Link
US (1) US20070053981A1 (de)
EP (1) EP1646404B1 (de)
JP (1) JP2007522086A (de)
AT (1) ATE454906T1 (de)
DE (1) DE602004025113D1 (de)
ES (1) ES2338009T3 (de)
WO (1) WO2005004921A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
EP1755566A2 (de) * 2004-06-15 2007-02-28 Teva Pharmaceutical Industries Ltd Stabile pharmazeutische formulierungen von benzimidazolverbindungen
US20090068263A1 (en) * 2006-04-20 2009-03-12 Themis Laboratories Private Limited Multiple unit compositions
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
ITMI20062290A1 (it) * 2006-11-28 2008-05-29 Monteres S R L Compresse stabili allo stoccaggio a base di derivati del benzimidazolo rivestite con film gastro-resistente
JP2012072061A (ja) * 2009-01-29 2012-04-12 Eisai R & D Management Co Ltd 新規組成物
US20110066141A1 (en) * 2009-09-11 2011-03-17 Cook Incorporated Implantable medical device having an anti-gastric distress agent
US20140179637A1 (en) 2012-12-21 2014-06-26 The Research Foundation For The State University Of New York Methods and compounds to inhibit enveloped virus release
GB2535130B (en) * 2014-09-29 2020-09-02 Veriton Pharma Ltd A Suspension
CN107530294B (zh) * 2015-03-31 2021-11-30 莱博瑞特瑞欧斯巴戈公司 含有质子泵抑制剂的肠溶包衣丸剂
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
CN105125507B (zh) * 2015-08-19 2018-03-06 德州德药制药有限公司 一种埃索美拉唑钠注射用冻干粉组合物及其制备方法
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US10946002B2 (en) * 2016-10-06 2021-03-16 Jubilant Generics Limited Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof
EP3720844A4 (de) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Arzneimittelzusammensetzungen
KR102006777B1 (ko) * 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
MX2021001905A (es) 2018-08-23 2021-04-28 Chong Kun Dang Pharmaceutical Corp Preparacion farmaceutica que tiene excelentes propiedades de disolucion, que contiene esomeprazol y bicarbonato de sodio.
US11666562B2 (en) 2020-04-02 2023-06-06 Northwestern University Ilaprazole for inhibiting the release of enveloped viruses from cells
WO2023137556A1 (en) * 2022-01-20 2023-07-27 Bionxt Solutions Inc. Chemical composition for enteric drug delivery
KR102553713B1 (ko) * 2022-11-18 2023-07-10 고덕상 미네랄 촉매제를 이용한 양식어류사료 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
DK0662320T3 (da) * 1991-08-30 2001-09-24 Showa Pharm Chem Ind Tør gelsammensætning
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
IT1270216B (it) * 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
PT1078628E (pt) * 1994-07-08 2009-01-27 Astrazeneca Ab Forma de dosagem em comprimidos com unidades múltiplas
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US5869118A (en) * 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
HK1040191A1 (zh) * 1998-07-31 2002-05-31 大塚制药株式会社 具有改良味道的药物组合物
WO2002026210A2 (en) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Proton pump inhibitor formulation

Also Published As

Publication number Publication date
US20070053981A1 (en) 2007-03-08
WO2005004921A1 (en) 2005-01-20
ES2338009T3 (es) 2010-05-03
EP1646404B1 (de) 2010-01-13
JP2007522086A (ja) 2007-08-09
EP1646404A1 (de) 2006-04-19
DE602004025113D1 (de) 2010-03-04

Similar Documents

Publication Publication Date Title
ATE454906T1 (de) Feste zusammensetzung mit einem protonenpumpenhemmer
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
EA200400777A1 (ru) Фармацевтические композиции соединения платины
JP2019131596A5 (de)
ATE450259T1 (de) Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoff
KR870009718A (ko) 경구용 산에 불안정한물질의 약제
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
WO2007078874A3 (en) Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
JP2013209416A (ja) 胃の逆流抵抗性投薬形態
PL358103A1 (pl) Hydrofilowe molekularne roztwory dyspersyjne karwedilolu
KR880008803A (ko) 핵을 갖는 구형 과립 및 그의 제조방법
NO20060185L (no) Anvendelse av isomalt (blanding av 1,6 GPS og 1,1 GPM) som prebiotikum blant annet for fremstilling av et legemiddel for behandling av tarmsykdommer
JP2005503399A5 (de)
GEP20043285B (en) Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
ATE466008T1 (de) P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
CA2502731A1 (en) Sustained release composition for oral administration of drugs
DE60229295D1 (de) Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält
RU2005105302A (ru) Композиция бицифадина
CN204890930U (zh) 一种消化内科食道涂药器
ATE462419T1 (de) Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
TWI482632B (zh) 醫藥用載體及使用該載體的藥物結構
ATE267162T1 (de) Therapeutisch und/oder ernährungsphysiologisch verbesserte derivate aktiver inhaltsstoffe und oral verabreichbare zusammensetzungen, die diese enthalten
WO2002062299A3 (en) Improved controlled release oral dosage form

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties